Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Exponent, Inc. (EXPO) Balance Sheet

As of 2026-07-03 (10-Q), Exponent, Inc. (EXPO) reported total assets of $652.7M, total liabilities of $364.1M and shareholders' equity of $288.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $66.6M.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

EXPOExponent, Inc.Follow EXPO — free
Engineering & Construction · Industrials
—
Price chart with a free account
Market cap
3.7B
P/E TTM
34.7
Dividend yield
1.6%
52-week
—
Next earnings
29 Oct, in 4 days
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Jan 14
FY2014
Jan 15
FY2015
Jan 16
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Jan 20
FY2020
Jan 21
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Jan 25
FY2025
Jan 26
Latest
Jul 26
Trend
Cash and equivalents84.4113.3122.9129.5125.8115.0124.8127.1176.4197.5297.7161.5187.2258.9221.966.6
Short-term investments25.320.933.224.945.858.871.681.555.245.0——————
Receivables73.185.477.086.488.687.4110.1105.8120.1111.6139.9170.1167.4161.4181.5218.5
Inventory0.70.40.0—————————————
Current assets198.6235.4251.7255.5272.8274.0315.5326.6364.0366.8452.8349.2379.5446.9427.6312.0
Total assets268.8315.4344.2365.3387.5403.7439.6468.9563.4580.1683.7586.7646.8777.3777.5652.7
Current liabilities60.871.872.179.380.580.293.198.3124.0117.3153.0159.0161.9163.2178.0157.8
Total liabilities82.199.0109.1121.0124.7130.4150.5155.0213.2218.6266.7265.9290.7356.2387.2364.1
Shareholders' equity186.7216.4235.1244.3262.8273.3289.1313.9350.3361.5417.1320.8356.1421.1390.3288.6

USD millions · SEC XBRL

Exponent, Inc. — questions

How much cash does Exponent, Inc. have?
$66.6M in cash and cash equivalents as of 2026-07-03.
What are Exponent, Inc.'s total assets?
$652.7M as of 2026-07-03.
What is Exponent, Inc.'s shareholders' equity?
$288.6M as of 2026-07-03.

Every figure on this page comes from Exponent, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.